Overview
Raw Data
1
Standard Curves
1.1
Prolactin
1.1.1
Data
1.1.2
CV
1.1.3
Standard curves
1.1.4
Session info
1.2
HPL
1.2.1
Data
1.2.2
CV
1.2.3
Standard curves
1.2.4
Session info
1.3
GH2
1.3.1
Data
1.3.2
CV
1.3.3
Standard curves
1.3.4
Session info
2
Plate Effect
2.1
Prolactin
2.1.1
Model summary
2.1.2
Sample descriptives
2.2
HPL
2.2.1
Model summary
2.2.2
Sample descriptives
2.3
GH2
2.3.1
Model summary
2.3.2
Sample descriptives
2.4
Session info
3
Flowchart
Association with Factors
4
Descriptives
4.1
By Study
4.1.1
Demographics
4.1.2
MetS
4.1.3
Outcomes
5
Folate vs FA supplement
5.0.1
FA supp (3 categories)
5.0.2
FA supp (4 categories)
5.1
Folate
5.1.1
FA supp (3 categories)
5.1.2
FA supp (4 categories)
5.2
B12
5.2.1
FA supp (3 categories)
5.2.2
FA supp (4 categories)
5.3
Homocysteine
5.3.1
FA supp (3 categories)
5.3.2
FA supp (4 categories)
5.4
Active B12
5.4.1
FA supp (3 categories)
5.4.2
FA supp (4 categories)
5.5
Folate:B12
5.5.1
FA supp (3 categories)
5.5.2
FA supp (4 categories)
5.6
Folate:Active B12
5.6.1
FA supp (3 categories)
5.6.2
FA supp (4 categories)
6
RCF (categories 2) vs Folate
6.1
Folate
6.1.1
Model summary
6.1.2
Comparisons
6.2
B12
6.2.1
Model summary
6.2.2
Comparisons
6.3
Homocysteine
6.3.1
Model summary
6.3.2
Comparisons
6.4
Active B12
6.4.1
Model summary
6.4.2
Comparisons
6.5
Folate:B12
6.5.1
Model summary
6.5.2
Comparisons
6.6
Folate:Active B12
6.6.1
Model summary
6.6.2
Comparisons
7
FA supp: 3 categories
7.1
Prolactin
7.2
HPL
7.3
GH2
7.4
Insulin
7.5
HOMA-IR
7.6
Glucose
8
FA supp: 4 categories
8.1
Prolactin
8.2
HPL
8.3
GH2
8.4
Insulin
8.5
HOMA-IR
8.6
Glucose
9
Age groups
9.1
Prolactin
9.2
HPL
9.3
GH2
9.4
Insulin
9.5
HOMA-IR
9.6
Glucose
9.7
Folate
9.8
CRP
9.9
RCF
10
BMI groups
10.1
Prolactin
10.2
HPL
10.3
GH2
10.4
Insulin
10.5
HOMA-IR
10.6
Glucose
10.7
Folate
10.8
CRP
10.9
RCF
11
Age & BMI groups
11.1
Prolactin
11.2
HPL
11.3
GH2
11.4
Insulin
11.5
HOMA-IR
11.6
Glucose
11.7
Folate
11.8
CRP
11.9
RCF
12
MetS
12.1
Prolactin
12.2
HPL
12.3
GH2
12.4
Insulin
12.5
HOMA-IR
12.6
Glucose
12.7
Folate
12.8
CRP
12.9
RCF
13
Birthweight centile
13.1
Prolactin
13.2
HPL
13.3
GH2
13.4
Insulin
13.5
HOMA-IR
13.6
Glucose
13.7
Folate
13.8
CRP
13.9
RCF
14
Hormone Models
14.1
Raw plots
14.2
SCOPE vs STOP
14.2.1
Global tests
14.2.2
Model summary
14.2.3
Diagnostics
14.2.4
Estimated means
14.2.5
Comparisons
14.2.6
Barplots by Study
14.2.7
Plots for GA
14.3
Folate
14.3.1
Global tests
14.3.2
Model summary
14.3.3
Estimated means
14.3.4
Comparisons
14.3.5
Diagnostics
14.3.6
Plots
14.4
Folate (categories)
14.4.1
Global tests
14.4.2
Model summary
14.4.3
Estimated means
14.4.4
Comparisons (Overall)
14.4.5
Diagnostics
14.4.6
Plots
14.5
Folate (categories 2)
14.5.1
Global tests
14.5.2
Model summary
14.5.3
Estimated means
14.5.4
Comparisons (Overall)
14.5.5
Diagnostics
14.5.6
Plots
14.6
B12
14.6.1
Global tests
14.6.2
Model summary
14.6.3
Estimated means
14.6.4
Comparisons
14.6.5
Estimated means (50 unit increase)
14.6.6
Comparisons (50 unit increase)
14.6.7
Diagnostics
14.6.8
Plots
14.7
Folate:B12
14.7.1
Global tests
14.7.2
Model summary
14.7.3
Estimated means
14.7.4
Comparisons
14.7.5
Diagnostics
14.7.6
Plots
14.8
Active B12
14.8.1
Global tests
14.8.2
Model summary
14.8.3
Estimated means
14.8.4
Comparisons
14.8.5
Diagnostics
14.8.6
Plots
14.9
Folate:Active B12
14.9.1
Global tests
14.9.2
Model summary
14.9.3
Estimated means
14.9.4
Comparisons
14.9.5
Diagnostics
14.9.6
Plots
14.10
Homocysteine
14.10.1
Global tests
14.10.2
Model summary
14.10.3
Estimated means
14.10.4
Comparisons
14.10.5
Diagnostics
14.10.6
Plots
14.11
Red cell folate
14.11.1
Global tests
14.11.2
Model summary
14.11.3
Diagnostics
14.11.4
Plots
14.12
Red cell folate (categories)
14.12.1
Global tests
14.12.2
Model summary
14.12.3
Diagnostics
14.12.4
Estimated marginal means
14.12.5
Plots
14.12.6
Post-hoc comparisons
14.13
Red cell folate (categories 2)
14.13.1
Global tests
14.13.2
Model summary
14.13.3
Diagnostics
14.13.4
Estimated marginal means
14.13.5
Plots
14.13.6
Post-hoc comparisons
14.14
Red cell folate (categories 3)
14.14.1
Global tests
14.14.2
Model summary
14.14.3
Diagnostics
14.14.4
Estimated marginal means
14.14.5
Plots
14.14.6
Post-hoc comparisons
15
Session info
Uncomplicated Pregnancies
16
Descriptives
16.1
By Study
16.1.1
Demographics
16.1.2
MetS
16.1.3
Outcomes
17
Folate vs FA supplement
17.0.1
FA supp (3 categories)
17.0.2
FA supp (4 categories)
17.1
Folate
17.1.1
FA supp (3 categories)
17.1.2
FA supp (4 categories)
17.2
B12
17.2.1
FA supp (3 categories)
17.2.2
FA supp (4 categories)
17.3
Homocysteine
17.3.1
FA supp (3 categories)
17.3.2
FA supp (4 categories)
17.4
Active B12
17.4.1
FA supp (3 categories)
17.4.2
FA supp (4 categories)
17.5
Folate:B12
17.5.1
FA supp (3 categories)
17.5.2
FA supp (4 categories)
17.6
Folate:Active B12
17.6.1
FA supp (3 categories)
17.6.2
FA supp (4 categories)
18
RCF (categories 2) vs Folate
18.1
Folate
18.1.1
Model summary
18.1.2
Comparisons
18.2
B12
18.2.1
Model summary
18.2.2
Comparisons
18.3
Homocysteine
18.3.1
Model summary
18.3.2
Comparisons
18.4
Active B12
18.4.1
Model summary
18.4.2
Comparisons
18.5
Folate:B12
18.5.1
Model summary
18.5.2
Comparisons
18.6
Folate:Active B12
18.6.1
Model summary
18.6.2
Comparisons
19
FA supp: 3 categories
19.1
Prolactin
19.2
HPL
19.3
GH2
19.4
Insulin
19.5
HOMA-IR
19.6
Glucose
20
FA supp: 4 categories
20.1
Prolactin
20.2
HPL
20.3
GH2
20.4
Insulin
20.5
HOMA-IR
20.6
Glucose
21
Age groups
21.1
Prolactin
21.2
HPL
21.3
GH2
21.4
Insulin
21.5
HOMA-IR
21.6
Glucose
21.7
Folate
21.8
CRP
21.9
RCF
22
BMI groups
22.1
Prolactin
22.2
HPL
22.3
GH2
22.4
Insulin
22.5
HOMA-IR
22.6
Glucose
22.7
Folate
22.8
CRP
22.9
RCF
23
Age & BMI groups
23.1
Prolactin
23.2
HPL
23.3
GH2
23.4
Insulin
23.5
HOMA-IR
23.6
Glucose
23.7
Folate
23.8
CRP
23.9
RCF
24
MetS
24.1
Prolactin
24.2
HPL
24.3
GH2
24.4
Insulin
24.5
HOMA-IR
24.6
Glucose
24.7
Folate
24.8
CRP
24.9
RCF
25
Birthweight centile
25.1
Prolactin
25.2
HPL
25.3
GH2
25.4
Insulin
25.5
HOMA-IR
25.6
Glucose
25.7
Folate
25.8
CRP
25.9
RCF
26
Hormone Models
26.1
Raw plots
26.2
SCOPE vs STOP
26.2.1
Global tests
26.2.2
Model summary
26.2.3
Diagnostics
26.2.4
Estimated means
26.2.5
Comparisons
26.2.6
Barplots by Study
26.2.7
Plots for GA
26.3
Folate
26.3.1
Global tests
26.3.2
Model summary
26.3.3
Estimated means
26.3.4
Comparisons
26.3.5
Diagnostics
26.3.6
Plots
26.4
Folate (categories)
26.4.1
Global tests
26.4.2
Model summary
26.4.3
Estimated means
26.4.4
Comparisons (Overall)
26.4.5
Diagnostics
26.4.6
Plots
26.5
Folate (categories 2)
26.5.1
Global tests
26.5.2
Model summary
26.5.3
Estimated means
26.5.4
Comparisons (Overall)
26.5.5
Diagnostics
26.5.6
Plots
26.6
B12
26.6.1
Global tests
26.6.2
Model summary
26.6.3
Estimated means
26.6.4
Comparisons
26.6.5
Estimated means (50 unit increase)
26.6.6
Comparisons (50 unit increase)
26.6.7
Diagnostics
26.6.8
Plots
26.7
Folate:B12
26.7.1
Global tests
26.7.2
Model summary
26.7.3
Estimated means
26.7.4
Comparisons
26.7.5
Diagnostics
26.7.6
Plots
26.8
Active B12
26.8.1
Global tests
26.8.2
Model summary
26.8.3
Estimated means
26.8.4
Comparisons
26.8.5
Diagnostics
26.8.6
Plots
26.9
Folate:Active B12
26.9.1
Global tests
26.9.2
Model summary
26.9.3
Estimated means
26.9.4
Comparisons
26.9.5
Diagnostics
26.9.6
Plots
26.10
Homocysteine
26.10.1
Global tests
26.10.2
Model summary
26.10.3
Estimated means
26.10.4
Comparisons
26.10.5
Diagnostics
26.10.6
Plots
26.11
Red cell folate
26.11.1
Global tests
26.11.2
Model summary
26.11.3
Diagnostics
26.11.4
Plots
26.12
Red cell folate (categories)
26.12.1
Global tests
26.12.2
Model summary
26.12.3
Diagnostics
26.12.4
Estimated marginal means
26.12.5
Plots
26.12.6
Post-hoc comparisons
26.13
Red cell folate (categories 2)
26.13.1
Global tests
26.13.2
Model summary
26.13.3
Diagnostics
26.13.4
Estimated marginal means
26.13.5
Plots
26.13.6
Post-hoc comparisons
26.14
Red cell folate (categories 3)
26.14.1
Global tests
26.14.2
Model summary
26.14.3
Diagnostics
26.14.4
Estimated marginal means
26.14.5
Plots
26.14.6
Post-hoc comparisons
27
Session info
GDM Cases
28
Descriptives
28.1
By Study
28.1.1
Demographics
28.1.2
MetS
28.1.3
Outcomes
29
Folate vs FA supplement
29.0.1
FA supp (3 categories)
29.0.2
FA supp (4 categories)
29.1
Folate
29.1.1
FA supp (3 categories)
29.1.2
FA supp (4 categories)
29.2
B12
29.2.1
FA supp (3 categories)
29.2.2
FA supp (4 categories)
29.3
Homocysteine
29.3.1
FA supp (3 categories)
29.3.2
FA supp (4 categories)
29.4
Active B12
29.4.1
FA supp (3 categories)
29.4.2
FA supp (4 categories)
29.5
Folate:B12
29.5.1
FA supp (3 categories)
29.5.2
FA supp (4 categories)
29.6
Folate:Active B12
29.6.1
FA supp (3 categories)
29.6.2
FA supp (4 categories)
30
RCF (categories 2) vs Folate
30.1
Folate
30.1.1
Model summary
30.1.2
Comparisons
30.2
B12
30.2.1
Model summary
30.2.2
Comparisons
30.3
Homocysteine
30.3.1
Model summary
30.3.2
Comparisons
30.4
Active B12
30.4.1
Model summary
30.4.2
Comparisons
30.5
Folate:B12
30.5.1
Model summary
30.5.2
Comparisons
30.6
Folate:Active B12
30.6.1
Model summary
30.6.2
Comparisons
31
FA supp: 3 categories
31.1
Prolactin
31.2
HPL
31.3
GH2
31.4
Insulin
31.5
HOMA-IR
31.6
Glucose
32
FA supp: 4 categories
32.1
Prolactin
32.2
HPL
32.3
GH2
32.4
Insulin
32.5
HOMA-IR
32.6
Glucose
33
Age groups
33.1
Prolactin
33.2
HPL
33.3
GH2
33.4
Insulin
33.5
HOMA-IR
33.6
Glucose
33.7
Folate
33.8
CRP
33.9
RCF
34
BMI groups
34.1
Prolactin
34.2
HPL
34.3
GH2
34.4
Insulin
34.5
HOMA-IR
34.6
Glucose
34.7
Folate
34.8
CRP
34.9
RCF
35
Age & BMI groups
35.1
Prolactin
35.2
HPL
35.3
GH2
35.4
Insulin
35.5
HOMA-IR
35.6
Glucose
35.7
Folate
35.8
CRP
35.9
RCF
36
MetS
36.1
Prolactin
36.2
HPL
36.3
GH2
36.4
Insulin
36.5
HOMA-IR
36.6
Glucose
36.7
Folate
36.8
CRP
36.9
RCF
37
Birthweight centile
37.1
Prolactin
37.2
HPL
37.3
GH2
37.4
Insulin
37.5
HOMA-IR
37.6
Glucose
37.7
Folate
37.8
CRP
37.9
RCF
38
Hormone Models
38.1
Raw plots
38.2
SCOPE vs STOP
38.2.1
Global tests
38.2.2
Model summary
38.2.3
Diagnostics
38.2.4
Estimated means
38.2.5
Comparisons
38.2.6
Barplots by Study
38.2.7
Plots for GA
38.3
Folate
38.3.1
Global tests
38.3.2
Model summary
38.3.3
Estimated means
38.3.4
Comparisons
38.3.5
Diagnostics
38.3.6
Plots
38.4
Folate (categories)
38.4.1
Global tests
38.4.2
Model summary
38.4.3
Estimated means
38.4.4
Comparisons (Overall)
38.4.5
Diagnostics
38.4.6
Plots
38.5
Folate (categories 2)
38.5.1
Global tests
38.5.2
Model summary
38.5.3
Estimated means
38.5.4
Comparisons (Overall)
38.5.5
Diagnostics
38.5.6
Plots
38.6
B12
38.6.1
Global tests
38.6.2
Model summary
38.6.3
Estimated means
38.6.4
Comparisons
38.6.5
Estimated means (50 unit increase)
38.6.6
Comparisons (50 unit increase)
38.6.7
Diagnostics
38.6.8
Plots
38.7
Folate:B12
38.7.1
Global tests
38.7.2
Model summary
38.7.3
Estimated means
38.7.4
Comparisons
38.7.5
Diagnostics
38.7.6
Plots
38.8
Active B12
38.8.1
Global tests
38.8.2
Model summary
38.8.3
Estimated means
38.8.4
Comparisons
38.8.5
Diagnostics
38.8.6
Plots
38.9
Folate:Active B12
38.9.1
Global tests
38.9.2
Model summary
38.9.3
Estimated means
38.9.4
Comparisons
38.9.5
Diagnostics
38.9.6
Plots
38.10
Homocysteine
38.10.1
Global tests
38.10.2
Model summary
38.10.3
Estimated means
38.10.4
Comparisons
38.10.5
Diagnostics
38.10.6
Plots
38.11
Red cell folate
38.11.1
Global tests
38.11.2
Model summary
38.11.3
Diagnostics
38.11.4
Plots
38.12
Red cell folate (categories)
38.12.1
Global tests
38.12.2
Model summary
38.12.3
Diagnostics
38.12.4
Estimated marginal means
38.12.5
Plots
38.12.6
Post-hoc comparisons
38.13
Red cell folate (categories 2)
38.13.1
Global tests
38.13.2
Model summary
38.13.3
Diagnostics
38.13.4
Estimated marginal means
38.13.5
Plots
38.13.6
Post-hoc comparisons
38.14
Red cell folate (categories 3)
38.14.1
Global tests
38.14.2
Model summary
38.14.3
Diagnostics
38.14.4
Estimated marginal means
38.14.5
Plots
38.14.6
Post-hoc comparisons
39
Session info
Non-GDM Cases
40
Descriptives
40.1
By Study
40.1.1
Demographics
40.1.2
MetS
40.1.3
Outcomes
41
Folate vs FA supplement
41.0.1
FA supp (3 categories)
41.0.2
FA supp (4 categories)
41.1
Folate
41.1.1
FA supp (3 categories)
41.1.2
FA supp (4 categories)
41.2
B12
41.2.1
FA supp (3 categories)
41.2.2
FA supp (4 categories)
41.3
Homocysteine
41.3.1
FA supp (3 categories)
41.3.2
FA supp (4 categories)
41.4
Active B12
41.4.1
FA supp (3 categories)
41.4.2
FA supp (4 categories)
41.5
Folate:B12
41.5.1
FA supp (3 categories)
41.5.2
FA supp (4 categories)
41.6
Folate:Active B12
41.6.1
FA supp (3 categories)
41.6.2
FA supp (4 categories)
42
RCF (categories 2) vs Folate
42.1
Folate
42.1.1
Model summary
42.1.2
Comparisons
42.2
B12
42.2.1
Model summary
42.2.2
Comparisons
42.3
Homocysteine
42.3.1
Model summary
42.3.2
Comparisons
42.4
Active B12
42.4.1
Model summary
42.4.2
Comparisons
42.5
Folate:B12
42.5.1
Model summary
42.5.2
Comparisons
42.6
Folate:Active B12
42.6.1
Model summary
42.6.2
Comparisons
43
FA supp: 3 categories
43.1
Prolactin
43.2
HPL
43.3
GH2
43.4
Insulin
43.5
HOMA-IR
43.6
Glucose
44
FA supp: 4 categories
44.1
Prolactin
44.2
HPL
44.3
GH2
44.4
Insulin
44.5
HOMA-IR
44.6
Glucose
45
Age groups
45.1
Prolactin
45.2
HPL
45.3
GH2
45.4
Insulin
45.5
HOMA-IR
45.6
Glucose
45.7
Folate
45.8
CRP
45.9
RCF
46
BMI groups
46.1
Prolactin
46.2
HPL
46.3
GH2
46.4
Insulin
46.5
HOMA-IR
46.6
Glucose
46.7
Folate
46.8
CRP
46.9
RCF
47
Age & BMI groups
47.1
Prolactin
47.2
HPL
47.3
GH2
47.4
Insulin
47.5
HOMA-IR
47.6
Glucose
47.7
Folate
47.8
CRP
47.9
RCF
48
MetS
48.1
Prolactin
48.2
HPL
48.3
GH2
48.4
Insulin
48.5
HOMA-IR
48.6
Glucose
48.7
Folate
48.8
CRP
48.9
RCF
49
Birthweight centile
49.1
Prolactin
49.2
HPL
49.3
GH2
49.4
Insulin
49.5
HOMA-IR
49.6
Glucose
49.7
Folate
49.8
CRP
49.9
RCF
50
Hormone Models
50.1
Raw plots
50.2
SCOPE vs STOP
50.2.1
Global tests
50.2.2
Model summary
50.2.3
Diagnostics
50.2.4
Estimated means
50.2.5
Comparisons
50.2.6
Barplots by Study
50.2.7
Plots for GA
50.3
Folate
50.3.1
Global tests
50.3.2
Model summary
50.3.3
Estimated means
50.3.4
Comparisons
50.3.5
Diagnostics
50.3.6
Plots
50.4
Folate (categories)
50.4.1
Global tests
50.4.2
Model summary
50.4.3
Estimated means
50.4.4
Comparisons (Overall)
50.4.5
Diagnostics
50.4.6
Plots
50.5
Folate (categories 2)
50.5.1
Global tests
50.5.2
Model summary
50.5.3
Estimated means
50.5.4
Comparisons (Overall)
50.5.5
Diagnostics
50.5.6
Plots
50.6
B12
50.6.1
Global tests
50.6.2
Model summary
50.6.3
Estimated means
50.6.4
Comparisons
50.6.5
Estimated means (50 unit increase)
50.6.6
Comparisons (50 unit increase)
50.6.7
Diagnostics
50.6.8
Plots
50.7
Folate:B12
50.7.1
Global tests
50.7.2
Model summary
50.7.3
Estimated means
50.7.4
Comparisons
50.7.5
Diagnostics
50.7.6
Plots
50.8
Active B12
50.8.1
Global tests
50.8.2
Model summary
50.8.3
Estimated means
50.8.4
Comparisons
50.8.5
Diagnostics
50.8.6
Plots
50.9
Folate:Active B12
50.9.1
Global tests
50.9.2
Model summary
50.9.3
Estimated means
50.9.4
Comparisons
50.9.5
Diagnostics
50.9.6
Plots
50.10
Homocysteine
50.10.1
Global tests
50.10.2
Model summary
50.10.3
Estimated means
50.10.4
Comparisons
50.10.5
Diagnostics
50.10.6
Plots
50.11
Red cell folate
50.11.1
Global tests
50.11.2
Model summary
50.11.3
Diagnostics
50.11.4
Plots
50.12
Red cell folate (categories)
50.12.1
Global tests
50.12.2
Model summary
50.12.3
Diagnostics
50.12.4
Estimated marginal means
50.12.5
Plots
50.12.6
Post-hoc comparisons
50.13
Red cell folate (categories 2)
50.13.1
Global tests
50.13.2
Model summary
50.13.3
Diagnostics
50.13.4
Estimated marginal means
50.13.5
Plots
50.13.6
Post-hoc comparisons
50.14
Red cell folate (categories 3)
50.14.1
Global tests
50.14.2
Model summary
50.14.3
Diagnostics
50.14.4
Estimated marginal means
50.14.5
Plots
50.14.6
Post-hoc comparisons
51
Session info
GDM vs Uncomplicated
52
Descriptives
52.1
Within SCOPE
52.1.1
Hormones
52.1.2
Demographics
52.1.3
MetS
52.1.4
Outcomes
52.2
Within STOP
52.2.1
Hormones
52.2.2
Demographics
52.2.3
MetS
52.2.4
Outcomes
52.3
SCOPE vs STOP (GDM)
52.3.1
Hormones
52.3.2
Demographics
52.3.3
MetS
52.3.4
Outcomes
52.4
SCOPE vs STOP (Uncomplicated)
52.4.1
Hormones
52.4.2
Demographics
52.4.3
MetS
52.4.4
Outcomes
53
Folate vs FA supplement
53.1
Folate
53.1.1
FA supp (4 categories)
53.1.2
Model summary
53.1.3
Estimated Marginal Means
53.1.4
Comparisons
53.2
B12
53.2.1
FA supp (4 categories)
53.2.2
Model summary
53.2.3
Estimated Marginal Means
53.2.4
Comparisons
53.3
Homocysteine
53.3.1
FA supp (4 categories)
53.3.2
Model summary
53.3.3
Estimated Marginal Means
53.3.4
Comparisons
53.4
Active B12
53.4.1
FA supp (4 categories)
53.4.2
Model summary
53.4.3
Estimated Marginal Means
53.4.4
Comparisons
53.5
Folate:B12
53.5.1
FA supp (4 categories)
53.5.2
Model summary
53.5.3
Estimated Marginal Means
53.5.4
Comparisons
53.6
Folate:Active B12
53.6.1
FA supp (4 categories)
53.6.2
Model summary
53.6.3
Estimated Marginal Means
53.6.4
Comparisons
54
Age groups
54.1
Prolactin
54.1.1
Model summary
54.1.2
Estimated marginal means
54.1.3
Post-hoc comparisons
54.2
HPL
54.2.1
Model summary
54.2.2
Estimated marginal means
54.2.3
Post-hoc comparisons
54.3
GH2
54.3.1
Model summary
54.3.2
Estimated marginal means
54.3.3
Post-hoc comparisons
54.4
Insulin
54.4.1
Model summary
54.4.2
Estimated marginal means
54.4.3
Post-hoc comparisons
54.5
HOMA-IR
54.5.1
Model summary
54.5.2
Estimated marginal means
54.5.3
Post-hoc comparisons
54.6
Glucose
54.6.1
Model summary
54.6.2
Estimated marginal means
54.6.3
Post-hoc comparisons
55
BMI groups
55.1
Prolactin
55.1.1
Model summary
55.1.2
Estimated marginal means
55.1.3
Post-hoc comparisons
55.2
HPL
55.2.1
Model summary
55.2.2
Estimated marginal means
55.2.3
Post-hoc comparisons
55.3
GH2
55.3.1
Model summary
55.3.2
Estimated marginal means
55.3.3
Post-hoc comparisons
55.4
Insulin
55.4.1
Model summary
55.4.2
Estimated marginal means
55.4.3
Post-hoc comparisons
55.5
HOMA-IR
55.5.1
Model summary
55.5.2
Estimated marginal means
55.5.3
Post-hoc comparisons
55.6
Glucose
55.6.1
Model summary
55.6.2
Estimated marginal means
55.6.3
Post-hoc comparisons
56
Age & BMI groups
56.1
Prolactin
56.1.1
Model summary
56.1.2
Estimated marginal means
56.1.3
Post-hoc comparisons
56.2
HPL
56.2.1
Model summary
56.2.2
Estimated marginal means
56.2.3
Post-hoc comparisons
56.3
GH2
56.3.1
Model summary
56.3.2
Estimated marginal means
56.3.3
Post-hoc comparisons
56.4
Insulin
56.4.1
Model summary
56.4.2
Estimated marginal means
56.4.3
Post-hoc comparisons
56.5
HOMA-IR
56.5.1
Model summary
56.5.2
Estimated marginal means
56.5.3
Post-hoc comparisons
56.6
Glucose
56.6.1
Model summary
56.6.2
Estimated marginal means
56.6.3
Post-hoc comparisons
57
MetS
57.1
Prolactin
57.1.1
Model summary
57.1.2
Estimated marginal means
57.1.3
Post-hoc comparisons
57.2
HPL
57.2.1
Model summary
57.2.2
Estimated marginal means
57.2.3
Post-hoc comparisons
57.3
GH2
57.3.1
Model summary
57.3.2
Estimated marginal means
57.3.3
Post-hoc comparisons
57.4
Insulin
57.4.1
Model summary
57.4.2
Estimated marginal means
57.4.3
Post-hoc comparisons
57.5
HOMA-IR
57.5.1
Model summary
57.5.2
Estimated marginal means
57.5.3
Post-hoc comparisons
57.6
Glucose
57.6.1
Model summary
57.6.2
Estimated marginal means
57.6.3
Post-hoc comparisons
58
Birthweight centile
58.1
Prolactin
58.1.1
Model summary
58.1.2
Estimated marginal means
58.1.3
Post-hoc comparisons
58.2
HPL
58.2.1
Model summary
58.2.2
Estimated marginal means
58.2.3
Post-hoc comparisons
58.3
GH2
58.3.1
Model summary
58.3.2
Estimated marginal means
58.3.3
Post-hoc comparisons
58.4
Insulin
58.4.1
Model summary
58.4.2
Estimated marginal means
58.4.3
Post-hoc comparisons
58.5
HOMA-IR
58.5.1
Model summary
58.5.2
Estimated marginal means
58.5.3
Post-hoc comparisons
58.6
Glucose
58.6.1
Model summary
58.6.2
Estimated marginal means
58.6.3
Post-hoc comparisons
59
Hormone Models
59.1
SCOPE vs STOP
59.1.1
Global tests
59.1.2
Model Summary
59.1.3
Diagnostics
59.1.4
Results
59.1.5
Comparisons
59.1.6
Comparisons by Timepoint
59.2
Folate
59.2.1
Global tests
59.2.2
Model summary
59.2.3
Estimated means
59.2.4
Comparisons
59.2.5
Diagnostics
59.2.6
Plots
59.3
B12
59.3.1
Global tests
59.3.2
Model summary
59.3.3
Estimated means
59.3.4
Comparisons
59.3.5
Estimated means (50 unit increase)
59.3.6
Comparisons (50 unit increase)
59.3.7
Diagnostics
59.3.8
Plots
59.4
Folate:B12
59.4.1
Global tests
59.4.2
Model summary
59.4.3
Estimated means
59.4.4
Comparisons
59.4.5
Diagnostics
59.4.6
Plots
59.5
Active B12
59.5.1
Global tests
59.5.2
Model summary
59.5.3
Estimated means
59.5.4
Comparisons
59.5.5
Diagnostics
59.5.6
Plots
59.6
Folate:Active B12
59.6.1
Global tests
59.6.2
Model summary
59.6.3
Estimated means
59.6.4
Comparisons
59.6.5
Diagnostics
59.6.6
Plots
59.7
Homocysteine
59.7.1
Global tests
59.7.2
Model summary
59.7.3
Estimated means
59.7.4
Comparisons
59.7.5
Diagnostics
59.7.6
Plots
GDM vs non-GDM
60
Descriptives
60.1
Within SCOPE
60.1.1
Hormones
60.1.2
Demographics
60.1.3
MetS
60.1.4
Outcomes
60.2
Within STOP
60.2.1
Hormones
60.2.2
Demographics
60.2.3
MetS
60.2.4
Outcomes
60.3
SCOPE vs STOP (GDM)
60.3.1
Hormones
60.3.2
Demographics
60.3.3
MetS
60.3.4
Outcomes
60.4
SCOPE vs STOP (non-GDM)
60.4.1
Hormones
60.4.2
Demographics
60.4.3
MetS
60.4.4
Outcomes
61
Folate vs FA supplement
61.1
Folate
61.1.1
FA supp (4 categories)
61.1.2
Model summary
61.1.3
Estimated Marginal Means
61.1.4
Comparisons
61.2
B12
61.2.1
FA supp (4 categories)
61.2.2
Model summary
61.2.3
Estimated Marginal Means
61.2.4
Comparisons
61.3
Homocysteine
61.3.1
FA supp (4 categories)
61.3.2
Model summary
61.3.3
Estimated Marginal Means
61.3.4
Comparisons
61.4
Active B12
61.4.1
FA supp (4 categories)
61.4.2
Model summary
61.4.3
Estimated Marginal Means
61.4.4
Comparisons
61.5
Folate:B12
61.5.1
FA supp (4 categories)
61.5.2
Model summary
61.5.3
Estimated Marginal Means
61.5.4
Comparisons
61.6
Folate:Active B12
61.6.1
FA supp (4 categories)
61.6.2
Model summary
61.6.3
Estimated Marginal Means
61.6.4
Comparisons
62
Age groups
62.1
Prolactin
62.1.1
Model summary
62.1.2
Estimated marginal means
62.1.3
Post-hoc comparisons
62.2
HPL
62.2.1
Model summary
62.2.2
Estimated marginal means
62.2.3
Post-hoc comparisons
62.3
GH2
62.3.1
Model summary
62.3.2
Estimated marginal means
62.3.3
Post-hoc comparisons
62.4
Insulin
62.4.1
Model summary
62.4.2
Estimated marginal means
62.4.3
Post-hoc comparisons
62.5
HOMA-IR
62.5.1
Model summary
62.5.2
Estimated marginal means
62.5.3
Post-hoc comparisons
62.6
Glucose
62.6.1
Model summary
62.6.2
Estimated marginal means
62.6.3
Post-hoc comparisons
63
BMI groups
63.1
Prolactin
63.1.1
Model summary
63.1.2
Estimated marginal means
63.1.3
Post-hoc comparisons
63.2
HPL
63.2.1
Model summary
63.2.2
Estimated marginal means
63.2.3
Post-hoc comparisons
63.3
GH2
63.3.1
Model summary
63.3.2
Estimated marginal means
63.3.3
Post-hoc comparisons
63.4
Insulin
63.4.1
Model summary
63.4.2
Estimated marginal means
63.4.3
Post-hoc comparisons
63.5
HOMA-IR
63.5.1
Model summary
63.5.2
Estimated marginal means
63.5.3
Post-hoc comparisons
63.6
Glucose
63.6.1
Model summary
63.6.2
Estimated marginal means
63.6.3
Post-hoc comparisons
64
Age & BMI groups
64.1
Prolactin
64.1.1
Model summary
64.1.2
Estimated marginal means
64.1.3
Post-hoc comparisons
64.2
HPL
64.2.1
Model summary
64.2.2
Estimated marginal means
64.2.3
Post-hoc comparisons
64.3
GH2
64.3.1
Model summary
64.3.2
Estimated marginal means
64.3.3
Post-hoc comparisons
64.4
Insulin
64.4.1
Model summary
64.4.2
Estimated marginal means
64.4.3
Post-hoc comparisons
64.5
HOMA-IR
64.5.1
Model summary
64.5.2
Estimated marginal means
64.5.3
Post-hoc comparisons
64.6
Glucose
64.6.1
Model summary
64.6.2
Estimated marginal means
64.6.3
Post-hoc comparisons
65
MetS
65.1
Prolactin
65.1.1
Model summary
65.1.2
Estimated marginal means
65.1.3
Post-hoc comparisons
65.2
HPL
65.2.1
Model summary
65.2.2
Estimated marginal means
65.2.3
Post-hoc comparisons
65.3
GH2
65.3.1
Model summary
65.3.2
Estimated marginal means
65.3.3
Post-hoc comparisons
65.4
Insulin
65.4.1
Model summary
65.4.2
Estimated marginal means
65.4.3
Post-hoc comparisons
65.5
HOMA-IR
65.5.1
Model summary
65.5.2
Estimated marginal means
65.5.3
Post-hoc comparisons
65.6
Glucose
65.6.1
Model summary
65.6.2
Estimated marginal means
65.6.3
Post-hoc comparisons
66
Birthweight centile
66.1
Prolactin
66.1.1
Model summary
66.1.2
Estimated marginal means
66.1.3
Post-hoc comparisons
66.2
HPL
66.2.1
Model summary
66.2.2
Estimated marginal means
66.2.3
Post-hoc comparisons
66.3
GH2
66.3.1
Model summary
66.3.2
Estimated marginal means
66.3.3
Post-hoc comparisons
66.4
Insulin
66.4.1
Model summary
66.4.2
Estimated marginal means
66.4.3
Post-hoc comparisons
66.5
HOMA-IR
66.5.1
Model summary
66.5.2
Estimated marginal means
66.5.3
Post-hoc comparisons
66.6
Glucose
66.6.1
Model summary
66.6.2
Estimated marginal means
66.6.3
Post-hoc comparisons
67
Hormone Models
67.1
SCOPE vs STOP
67.1.1
Global tests
67.1.2
Model Summary
67.1.3
Diagnostics
67.1.4
Results
67.1.5
Comparisons by Timepoint
67.2
Folate
67.2.1
Global tests
67.2.2
Model summary
67.2.3
Estimated means
67.2.4
Comparisons
67.2.5
Diagnostics
67.2.6
Plots
67.3
B12
67.3.1
Global tests
67.3.2
Model summary
67.3.3
Estimated means
67.3.4
Comparisons
67.3.5
Estimated means (50 unit increase)
67.3.6
Comparisons (50 unit increase)
67.3.7
Diagnostics
67.3.8
Plots
67.4
Folate:B12
67.4.1
Global tests
67.4.2
Model summary
67.4.3
Estimated means
67.4.4
Comparisons
67.4.5
Diagnostics
67.4.6
Plots
67.5
Active B12
67.5.1
Global tests
67.5.2
Model summary
67.5.3
Estimated means
67.5.4
Comparisons
67.5.5
Diagnostics
67.5.6
Plots
67.6
Folate:Active B12
67.6.1
Global tests
67.6.2
Model summary
67.6.3
Estimated means
67.6.4
Comparisons
67.6.5
Diagnostics
67.6.6
Plots
67.7
Homocysteine
67.7.1
Global tests
67.7.2
Model summary
67.7.3
Estimated means
67.7.4
Comparisons
67.7.5
Diagnostics
67.7.6
Plots
SCOPE & STOP Hormones Analysis
26.1
Raw plots
